# China NMPA Drug Inspection - Anhui Tongtai Tuozutang Pharmaceutical Co., Ltd. - Guangshanyao

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/anhui-tongtai-tuozutang-pharmaceutical-co-ltd/13d52e30-b130-4380-b182-0dc266279d14/
Source feed: China

> China NMPA drug inspection for Anhui Tongtai Tuozutang Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Guangshanyao. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Anhui Tongtai Tuozutang Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Guangshanyao
- Inspection Finding: [Inspect] Sulfur dioxide residue
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.globalkeysolutions.net/companies/anhui-tongtai-tuozutang-pharmaceutical-co-ltd/1c1cf1eb-9ef3-4d1c-b59c-6f28e8edd7dc/